Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;33(12):13346-13357.
doi: 10.1096/fj.201901161R. Epub 2019 Sep 21.

Endomucin restores depleted endothelial glycocalyx in the retinas of streptozotocin-induced diabetic rats

Affiliations

Endomucin restores depleted endothelial glycocalyx in the retinas of streptozotocin-induced diabetic rats

Tian Niu et al. FASEB J. 2019 Dec.

Abstract

Endothelial glycocalyx plays a significant role in the development and progression of diabetic complications. Endomucin (EMCN) is an anti-inflammatory membrane glycoprotein that is mainly expressed in venous and capillary endothelial cells. However, the function of EMCN in diabetic retinopathy (DR) progression is still completely unknown. We first investigated the change of EMCN expression in the retina and human retinal microvascular endothelial cells. We then overexpressed EMCN in the retina with adeno-associated virus and induced DR with streptozotocin (STZ). We analyzed EMCN's effect on the integrity of endothelial glycocalyx under conditions of DR. Furthermore, we investigated EMCN's protective effect against inflammation and blood-retinal barrier (BRB) destruction. We found that EMCN is specifically expressed in retinal endothelial cells and that its levels are decreased during hyperglycemia in vitro and in vivo. Overexpression of EMCN can restore the retinal endothelial glycocalyx of STZ-induced diabetic rats. Furthermore, EMCN overexpression can decrease leukocyte-endothelial adhesion to ameliorate inflammation and stabilize the BRB to inhibit vessel leakage in rats with DR. EMCN may protect patients with diabetes from retinal vascular degeneration by restoring the endothelial glycocalyx. EMCN may thus represent a novel therapeutic strategy for DR because it targets endothelial glycocalyx degradation associated with this disease.-Niu, T., Zhao, M., Jiang, Y., Xing, X., Shi, X., Cheng, L., Jin, H., Liu, K. Endomucin restores depleted endothelial glycocalyx in the retinas of streptozotocin-induced diabetic rats.

Keywords: blood-retinal barrier; diabetic retinopathy; inflammation.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Leasher, J. L., Bourne, R. R., Flaxman, S. R., Jonas, J. B., Keeffe, J., Naidoo, K., Pesudovs, K., Price, H., White, R. A., Wong, T. Y., Resnikoff, S., and Taylor, H. R.; Vision Loss Expert Group of the Global Burden of Disease Study. (2016) Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care 39, 1643-1649; erratum: 2096
    1. El-Asrar, A. M. (2012) Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East Afr. J. Ophthalmol. 19, 70-74
    1. Park, D. Y., Lee, J., Kim, J., Kim, K., Hong, S., Han, S., Kubota, Y., Augustin, H. G., Ding, L., Kim, J. W., Kim, H., He, Y., Adams, R. H., and Koh, G. Y. (2017) Plastic roles of pericytes in the blood-retinal barrier. Nat. Commun. 8, 15296
    1. Joussen, A. M., Murata, T., Tsujikawa, A., Kirchhof, B., Bursell, S. E., and Adamis, A. P. (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am. J. Pathol. 158, 147-152
    1. Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., Kern, T. S., and Adamis, A. P. (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 18, 1450-1452

Publication types

MeSH terms

LinkOut - more resources